Citations

"Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis." Clin Infect Dis 64, no. 8 (2017).

Baisley, K., J. Orne‐Gliemann, J. Larmarange, M. Plazy, D. Collier, J. Dreyer, T. Mngomezulu, K. Herbst, W. Hanekom, F. Dabis, M. J Siedner, and C. Iwuji. "Treat‐all strategy and long‐term survival among people living with HIV in South Africa: Results after 6 years of observation in the ANRS 12249 treatment as prevention trial.." HIV MED.

Baisley, K., J. Orne‐Gliemann, J. Larmarange, M. Plazy, D. Collier, J. Dreyer, T. Mngomezulu, K. Herbst, W. Hanekom, F. Dabis, M. J Siedner, and C. Iwuji. "Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial." HIV Medicine 23, no. 8 (2022): 922-928.